Home › Entities › clinical_trial › Topical Aprepitant in Prurigo Patients

Topical Aprepitant in Prurigo Patients

clinical trial
MedicalStudy clinical_trial Q61975894
Press Enter · cited answer in seconds

Summary

Topical Aprepitant in Prurigo Patients is a clinical trial[1].

Key Facts

  • Topical Aprepitant in Prurigo Patients is in the country of Germany[2].
  • Topical Aprepitant in Prurigo Patients's instance of is recorded as clinical trial[3].
  • Topical Aprepitant in Prurigo Patients's start time is recorded as +2013-10-31T00:00:00Z[4].
  • Topical Aprepitant in Prurigo Patients's end time is recorded as +2014-07-31T00:00:00Z[5].
  • Topical Aprepitant in Prurigo Patients's sponsor is recorded as Leo Pharma (Germany)[6].
  • Topical Aprepitant in Prurigo Patients's main subject is recorded as prurigo[7].
  • Topical Aprepitant in Prurigo Patients's number of participants is recorded as {'unit': '1', 'amount': '+20'}[8].
  • Topical Aprepitant in Prurigo Patients's title is recorded as Topical Aprepitant in Prurigo Patients An Exploratory Phase IIa Trial With Topically Applied Aprepitant in Patients With Prurigo[9].
  • Topical Aprepitant in Prurigo Patients's short name is recorded as iTAPP[10].
  • Topical Aprepitant in Prurigo Patients's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+18'}[11].
  • Topical Aprepitant in Prurigo Patients's ClinicalTrials.gov ID is recorded as NCT01963793[12].
  • Topical Aprepitant in Prurigo Patients's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}[13].
  • Topical Aprepitant in Prurigo Patients's research intervention is recorded as aprepitant[14].
  • Topical Aprepitant in Prurigo Patients's research intervention is recorded as fosaprepitant[15].
  • Topical Aprepitant in Prurigo Patients's clinical trial phase is recorded as phase II clinical trial[16].
  • Topical Aprepitant in Prurigo Patients's research subject recruitment status is recorded as completed[17].
  • Topical Aprepitant in Prurigo Patients's study type is recorded as interventional study[18].

References

Programmatic citations — every numbered marker resolves to a verifiable graph row below.

Direct Wikidata claims

  1. [2] ↑ . wikidata.org.
  2. [3] ↑ . wikidata.org.
  3. [4] ↑ . wikidata.org.
  4. [5] ↑ . wikidata.org.
  5. [6] ↑ . wikidata.org.
  6. [7] ↑ . wikidata.org.
  7. [8] ↑ . wikidata.org.
  8. [9] ↑ . wikidata.org.
  9. [10] ↑ . wikidata.org.
  10. [11] ↑ . wikidata.org.
  11. [12] ↑ . wikidata.org.
  12. [13] ↑ . wikidata.org.
  13. [14] ↑ . wikidata.org.
  14. [15] ↑ . wikidata.org.
  15. [16] ↑ . wikidata.org.
  16. [17] ↑ . wikidata.org.
  17. [18] ↑ . wikidata.org.

Class ancestry

  1. [1] ↑ . Wikidata. wikidata.org.

📑 Cite this page

Use these citations when quoting this entity in research, articles, AI prompts, or wherever provenance matters. We aggregate Wikidata + Wikipedia + authoritative open-data sources; the stitched, scored, cross-referenced view is what 4ort.xyz contributes.

APA 4ort.xyz Knowledge Graph. (2026). Topical Aprepitant in Prurigo Patients. Retrieved May 3, 2026, from https://4ort.xyz/entity/topical-aprepitant-in-prurigo-patients
MLA “Topical Aprepitant in Prurigo Patients.” 4ort.xyz Knowledge Graph, 4ort.xyz, 3 May. 2026, https://4ort.xyz/entity/topical-aprepitant-in-prurigo-patients.
BibTeX @misc{4ortxyz_topical-aprepitant-in-prurigo-patients_2026, author = {{4ort.xyz Knowledge Graph}}, title = {{Topical Aprepitant in Prurigo Patients}}, year = {2026}, url = {https://4ort.xyz/entity/topical-aprepitant-in-prurigo-patients}, note = {Accessed: 2026-05-03}}
LLM prompt According to 4ort.xyz Knowledge Graph (aggregator of Wikidata, Wikipedia, and authoritative open-data sources): Topical Aprepitant in Prurigo Patients — https://4ort.xyz/entity/topical-aprepitant-in-prurigo-patients (retrieved 2026-05-03)

Canonical URL: https://4ort.xyz/entity/topical-aprepitant-in-prurigo-patients · Last refreshed: